ResMed Insider Trades
NYSE: RMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 230.05 -0.03%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 26 · $17.76M
- Shares bought / sold
- 0 / 76.08K
- Net activity
- Net selling $17.8 million
ResMed insider activity
Over the last 12 months, ResMed insiders reported 45 transactions on SEC Form 4: 0 open-market purchases and 26 sales. Insiders bought $0 and sold $17.8 million worth of stock, for net insider selling of $17.8 million. The largest seller was Farrell Michael J., with $11.5 million in reported sales.
The most recent filing shows Farrell Michael J. (Chairman and CEO) reporting a transaction in 4,991 shares at $146.34 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RMD's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
RMD insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.11M | Form 4 |
| Sep 8, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Sep 2, 2026 | FARRELL PETER CDirector | Sale | 970 | $227.69K | Form 4 |
| Aug 14, 2026 | Bloomer AaronChief Financial Officer | Award | 9,072 | — | Form 4 |
| Aug 14, 2026 | Farrell Michael J.Chairman and CEO | Award | 13,547 | — | Form 4 |
| Aug 14, 2026 | Rider Michael JGlobal General Counsel | Award | 3,230 | — | Form 4 |
| Aug 14, 2026 | Leong JustinChief Product Officer | Award | 6,461 | — | Form 4 |
| Aug 7, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.03M | Form 4 |
| Aug 7, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Aug 5, 2026 | FARRELL PETER CDirector | Sale | 8,000 | $1.80M | Form 4 |
| Jul 7, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.09M | Form 4 |
| Jul 7, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Jun 8, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $968.06K | Form 4 |
| Jun 8, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Jun 1, 2026 | Rider Michael JGlobal General Counsel | Tax withholding | 269 | $51.21K | Form 4 |
| May 7, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.04M | Form 4 |
| May 7, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Apr 7, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.13M | Form 4 |
| Apr 7, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Apr 1, 2026 | FARRELL PETER CDirector | Sale | 2,000 | $450.00K | Form 4 |
| Apr 1, 2026 | Sandercock BrettChief Financial Officer | Sale | 1,000 | $224.31K | Form 4 |
| Mar 9, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.25M | Form 4 |
| Mar 9, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Mar 4, 2026 | FARRELL PETER CDirector | Sale | 2,000 | $520.44K | Form 4 |
| Mar 2, 2026 | Sandercock BrettChief Financial Officer | Sale | 1,000 | $254.30K | Form 4 |
| Feb 9, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.37M | Form 4 |
| Feb 9, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Feb 4, 2026 | Rider Michael JGlobal General Counsel | Sale | 50 | $13.00K | Form 4 |
| Feb 4, 2026 | FARRELL PETER CDirector | Sale | 2,000 | $502.62K | Form 4 |
| Feb 2, 2026 | Sandercock BrettChief Financial Officer | Sale | 1,000 | $257.03K | Form 4 |
| Jan 7, 2026 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.24M | Form 4 |
| Jan 7, 2026 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Jan 7, 2026 | FARRELL PETER CDirector | Sale | 2,000 | $497.66K | Form 4 |
| Jan 2, 2026 | Sandercock BrettChief Financial Officer | Sale | 1,000 | $241.75K | Form 4 |
| Jan 2, 2026 | Rider Michael JGlobal General Counsel | Sale | 50 | $12.09K | Form 4 |
| Dec 8, 2025 | Farrell Michael J.Chairman and CEO | Sale | 4,991 | $1.25M | Form 4 |
| Dec 8, 2025 | Farrell Michael J.Chairman and CEO | Option exercise | 4,991 | $730.38K | Form 4 |
| Dec 3, 2025 | FARRELL PETER CDirector | Sale | 2,000 | $502.94K | Form 4 |
| Dec 1, 2025 | Sandercock BrettChief Financial Officer | Sale | 1,000 | $244.16K | Form 4 |
| Dec 1, 2025 | Rider Michael JGlobal General Counsel | Sale | 50 | $12.21K | Form 4 |
| Nov 25, 2025 | De Witte JanDirector | Sale | 2,055 | $524.02K | Form 4 |
| Nov 20, 2025 | Tan DesneyDirector | Award | 1,073 | — | Form 4 |
| Nov 20, 2025 | Mowad-Nassar NicoleDirector | Award | 536 | — | Form 4 |
| Nov 20, 2025 | Hernandez JohnDirector | Award | 1,073 | — | Form 4 |
| Nov 20, 2025 | Leong JustinChief Product Officer | Award | 1,848 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4